Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit - BOSTON and ...

The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending ...

This brand offers a bunch of beds, but what should you know about their most popular AS3 mattress before you buy it for ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

The Eu­ro­pean Com­mis­sion is ask­ing bio­phar­ma and man­u­fac­tur­ing com­pa­nies about their re­ac­tion to No­vo ...

Gabbard has been accused of spreading Russian propaganda and former Secretary of State Hillary Rodham Clinton once referred ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...